DBI Antibody / Lipid Metabolism and Neurosteroid Regulation Marker Antibody (R32604)

DBI Antibody Human Placenta WB. Western blot analysis of human placenta lysate using DBI antibody detects a prominent band at approximately 10 kDa, consistent with the predicted molecular weight of DBI / Diazepam binding inhibitor, a lipid-binding protein involved in acyl-CoA transport, neurosteroid regulation, and intracellular metabolic signaling.

DBI Antibody Human Placenta IHC. Immunohistochemistry of FFPE human placenta tissue using DBI antibody demonstrates granular HRP-DAB brown cytoplasmic staining in placental trophoblast-associated cells, consistent with DBI / Diazepam binding inhibitor expression linked to intracellular lipid metabolism, steroid-associated signaling, and acyl-CoA-binding activity. HIER: steam sections in pH6 citrate buffer for 20 min.

DBI Antibody Prostate Cancer IHC. Immunohistochemistry of FFPE human prostate carcinoma tissue using DBI antibody shows granular HRP-DAB brown cytoplasmic staining in tumor epithelial cells, consistent with DBI / Diazepam binding inhibitor expression associated with intracellular lipid metabolism, neurosteroid-related pathways, and acyl-CoA-binding activity. HIER: steam sections in pH6 citrate buffer for 20 min.

DBI Antibody MCF7 FACS. Flow cytometry analysis of human MCF7 cells using DBI antibody demonstrates a strong rightward shift in fluorescence intensity compared to the isotype control, consistent with detection of DBI / Diazepam binding inhibitor, a lipid-binding protein involved in acyl-CoA metabolism and neurosteroid-associated signaling pathways; red histogram represents cells alone, green histogram represents isotype control, and blue histogram represents DBI antibody staining.

DBI Antibody PC-3 FACS. Flow cytometry analysis of human PC-3 cells using DBI antibody demonstrates a pronounced rightward shift in fluorescence intensity relative to the isotype control, consistent with detection of DBI / Diazepam binding inhibitor, an acyl-CoA-binding protein involved in intracellular lipid metabolism and neurosteroid-associated signaling pathways; red histogram represents cells alone, green histogram represents isotype control, and blue histogram represents DBI antibody staining.

DBI Antibody THP-1 FACS. Flow cytometry analysis of human THP-1 cells using DBI antibody demonstrates a clear rightward shift in fluorescence intensity compared to the isotype control, consistent with detection of DBI / Diazepam binding inhibitor, a lipid-binding protein involved in acyl-CoA transport, metabolic regulation, and neurosteroid-associated signaling; red histogram represents cells alone, green histogram represents isotype control, and blue histogram represents DBI antibody staining.

DBI Antibody U-2 OS IF. Immunofluorescence analysis of FFPE human U-2 OS cells using DBI antibody (green) demonstrates diffuse cytoplasmic staining consistent with DBI / Diazepam binding inhibitor localization associated with intracellular lipid metabolism and acyl-CoA-binding activity, while nuclei are counterstained with DAPI (blue). HIER: steam sections in pH6 citrate buffer for 20 min.